<DOC>
	<DOCNO>NCT02568319</DOCNO>
	<brief_summary>This multi-center , randomize , placebo-controlled , double-blind study evaluate safety efficacy LIPO-202 reduction central abdominal bulge obese subject .</brief_summary>
	<brief_title>Safety Efficacy Study LIPO-202 Reduction Central Abdominal Bulging Obese Subjects</brief_title>
	<detailed_description />
	<criteria>Healthy male nonpregnant female subject Capable provide write consent BMI &gt; 30 kg/m2 &lt; 40 kg/m2 Stable diet exercise routine At least `` Slightly Dissatisfied '' abdominal bulge Abdominal Contour Questionnaire ( ACQ ) BMI &gt; 40 kg/m2 Have treatment fat around abdomen , include surgical procedure ( tummy tuck , liposuction ) , injection fat loss treatment device reduce fat abdomen . Plan start weight loss exercise program study Known hypersensitivity study drug Have medical condition might complicate study procedure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>